SpaceX beat earnings expectations but disclosed AI spending levels that spooked investors.

Alphabet fell after its most important AI architect departed to start a competing company. Today’s edition covers both stories, the gold move nobody saw coming, and everything else that mattered.

A once-struggling computer maker has transformed into a major AI infrastructure company, winning support from Elon Musk, the Pentagon, and President Trump.

Louis Navellier says his system just gave the stock an A rating—and believes a major August 6 event could bring its full potential into focus.

See the company name and Navellier’s free analysis before tomorrow’s deadline.

One insider cashed out more than $2 million after his stock gained nearly 480% in a year and 58% in five sessions.

Elsewhere, two executives reported more than $36 million in sales near a 52-week high. But the option exercises underneath those transactions completely change the signal, and Insider readers are seeing which sale deserves the real caution.

Every day, insiders and institutions move millions before the market catches on. We surface the data behind those moves before the rest of the market sees it.

A subscription gets you:

$25/mo or $250/yr. 30-day money back guarantee. Cancel anytime. Founding member pricing: lock in $25/mo before we raise it.

SpaceX disclosed $18.4 billion in capital expenditures for the most recent quarter — more than Netflix’s entire 2025 revenue — sending its stock down 13%, while Musk’s comment that SpaceX would exclusively use Nvidia chips going forward knocked AMD down 6% and lifted Nvidia.

Jeff Dean, the Google engineer who co-created TensorFlow, built Google Brain, and drove its AI architecture for 15 years, left to co-found a new AI startup with three colleagues, cutting 4% off Alphabet’s valuation in one afternoon.

Gold surged past $4,300, and copper hit new records, with central bank buying resuming per World Gold Council data and the Fed’s decision to hold accelerating the precious metals thesis.

Shake Shack jumped after Starboard Value disclosed it had built a position worth several hundred million dollars in the burger chain. Uber fell 6% after guiding for softer Q3 revenue growth than analysts expected, despite beating Q2 on the top line.

GlobalFoundries reported revenue above Wall Street estimates as rising data-center demand lifted second-quarter sales to $1.79 billion, while adjusted earnings reached 46 cents per share.

AI infrastructure spending is increasing demand for the company’s silicon photonics chips, which move information faster inside data centers, while GlobalFoundries expects third-quarter revenue of roughly $1.89 billion.

Amazon’s Zoox will begin charging for robotaxi rides in Las Vegas next week, moving beyond free testing after receiving federal clearance to deploy vehicles without steering wheels or pedals.

The commercial launch places Amazon directly against Alphabet’s Waymo and Tesla, with Zoox pricing rides near the premium comfort tier and calculating fares through a base charge, travel time, and distance.

Axalta shareholders approved the company’s all-stock merger with Akzo Nobel, while investors in the Dutch coatings group also backed the transaction during a separate meeting held on August 5.

The combination will bring together two global suppliers of automotive and industrial coatings, although regulatory reviews and other closing conditions remain before the companies expect to complete the deal in late 2026 or early 2027.

International Flavors & Fragrances agreed to sell its Food Ingredients business to CVC Capital Partners for about $4.3 billion, leaving the company more focused on fragrances, taste products, health ingredients, and biotechnology.

IFF plans to use the proceeds to reduce debt by more than $1 billion and support a $2.5 billion share repurchase program, while operating with fewer manufacturing sites and investing a larger share of sales in research and development.

STERIS will invest $600 million in a new 600,000-square-foot manufacturing and distribution facility in North Carolina, relocating chemical operations from Missouri and Minnesota to a site near the Raleigh-Durham Research Triangle.

The facility will produce chemicals used for infection prevention and contamination control, begin operations within two to three years, and create about 335 jobs across manufacturing, research, development, and distribution.

DuPont expanded its Corian distribution network across the Mid-Atlantic and Midwest through broader partnerships with Hallmark Building Supplies and Parksite, increasing coverage across 10 states for construction, healthcare, architecture, and industrial customers.

The expanded network adds regional logistics, technical resources, samples, and customer support while helping DuPont distribute its 2026 Nature in Motion collection of Corian solid-surface and quartz products.

A small Colorado company now owns rights to a tech that could save the entire public power grid from collapse.

And billionaire Sam Altman is now an investor.

Click here to learn this company's name for free.

*This ad is sent on behalf of Altimetry, 110 Cambridge Street, Cambridge, MA 02141. If you would like to optout from receiving offers from Altimetry please click here.

Chipotle said its annual targets exclude any financial damage from a salmonella outbreak under investigation in Minnesota, where health officials have identified 110 related cases.

The restaurant chain removed jalapeños from affected locations and switched to different growers after tracing a common shipment, although investigators have not yet confirmed the ingredient as the outbreak’s definitive source.

Disney agreed to sell its 50% stake in A+E Global Media to Hearst for $1.2 billion in cash, giving its longtime partner full ownership of the company behind History and Lifetime.

The sale removes another traditional cable holding from Disney’s portfolio and gives the company additional cash for share repurchases as it concentrates more resources on Disney+, streaming, and digital entertainment.

CVS Health cut its MinuteClinic weight-loss visit price to $29 and partnered with Eli Lilly to make Zepbound and Foundayo pricing easier to view through the CVS Health app.

Eligible patients will gain access to insurance and cash-pay options, potential same-day medication pickup at roughly 9,000 CVS pharmacies, and virtual consultations without a membership or recurring monthly fee.

Citius Oncology expanded institutional adoption of LYMPHIR, with new treatment centers ordering the blood cancer therapy increasing 78% from the previous quarter.

LYMPHIR is now available at 42 institutions, while vial orders rose 31% and broader insurance coverage opened access to a cutaneous T-cell lymphoma market currently valued above $400 million.

INLIF Limited [INLF] $6.27 (+97.17%)

INLIF is a Chinese robotic arms manufacturer that has appeared in the top movers list repeatedly through the summer on reverse-split mechanics and defense-adjacent robotics demand.

Today it ran nearly 95% on 6x relative volume with no fresh company announcement, which makes this a technical momentum trade on a name where the float is tight enough that positioning moves create outsized price swings.

Julong Holding [JLHL] $9.35 (+72.51%)

Julong is a Chinese commercial services company that has been one of the summer’s most reliable momentum squeezes — it goes up 70%+ then gives it back, then does it again.

Today it ran on 164x relative volume, which is the clearest signal the move is positioning-driven. The pattern has repeated enough times this summer that calling it predictable wouldn’t be wrong.

Orion Energy Systems [OESX] $16.06 (+54.42%)

Orion makes LED lighting systems, IoT controls, and EV charging infrastructure for commercial buildings including warehouses, retail, and healthcare.

On a day when SpaceX disclosed spending $18 billion on data center infrastructure, Orion’s customer base — the commercial operators who need energy-efficient lighting and power solutions in those facilities — got a fresh reminder that the build is real and the service demand follows.

Strong Buy rated.

Suja Life [SUJA] $6.14 (-48.18%)

Suja Life makes cold-pressed juices and functional beverages sold through major US retailers.

The stock fell nearly 46% after the company reported Q2 results that missed expectations on revenue and gross margin, pointing to elevated production costs and softening consumer demand for premium refrigerated beverages as shoppers trade down.

Buy rated.

Autonomix Medical [AMIX] $12.10 (-37.95%)

Autonomix was up 502% yesterday on U.S. Patent 12,433,670 for cancer and organ function nerve mapping technology. It’s down 39% today.

The one-day patent bounce followed by a reversal of this size is exactly the lifecycle of a small-cap patent announcement that draws speculative interest rather than fundamental buyers.

The IP is real; the trading move wasn’t based on revenue. Strong Buy rated.

Limbach Holdings [LMB] $49.73 (-27.38%)

Limbach provides mechanical, electrical, and plumbing systems for complex commercial buildings — hospitals, data centers, universities.

The company reported Q2 results that disappointed on margin compression and project execution timing, sending shares down 35%.

For a company that had been a consistent outperformer this year, the magnitude of the miss caught investors off guard. Strong Buy rated.

Unplanned RMDs from your IRA or 401(k) can push you into a higher tax bracket.

Here are 6 strategies that could shrink those distributions and your tax bill.

See the 6 RMD strategies

That's it for today! Please, write us back, and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback!

Thanks for reading. I'll see you at the next open! 

Best Regards,
— Adam G.
Elite Trade Club

Click here to get our daily newsletter straight to your cell for free.

P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.